Skip to content

Clinical study on the treatment of Perimenopausal Insomnia with Yishen Pinggan Decoction

Clinical study on the treatment of Perimenopausal Insomnia with Yishen Pinggan Decoction

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000036264
Enrollment
Unknown
Registered
2020-08-22
Start date
2020-11-01
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perimenopausal Insomnia

Interventions

Sponsors

Shanghai Municipal Hospital Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Women aged 45-60 years; 2.Insomnia; 3.Perimenopausal symptoms; 4.PSQI>= 6and KI>=15; 5.No sedatives and sleeping pills,or Stop taking sleeping pills more than two weeks.

Exclusion criteria

Exclusion criteria: 1. Premature ovarian failure or bilateral ovariectomy due to other diseases; 2. With mental illness; 3. HAMA >= 14 and(or) HAMD >= 18; 4. Obvious symptoms of heart, liver, kidney or other systems; 5. Laboratory examination and ECG examination have obvious clinical significance abnormalities, which can affect the drug evaluation or the safety of the subjects; 7. AST and ALT were 2.0 times higher than the upper limit of normal value; 8. Those who have severe allergic constitution or are known to be allergic to traditional Chinese medicine ingredients used in this study; 9. Those who have severe allergic constitution or known to be allergic to traditional Chinese medicine ingredients used in this study have received sex hormone drug treatment or participated in other clinical trials in the past one month.

Design outcomes

Primary

MeasureTime frame
PSQI, KI, HAMA, HAMD;

Secondary

MeasureTime frame
TCM symptom scale;

Countries

China

Contacts

Public Contactwanghuiru

Shanghai Traditional Chinese Medicine Hospital

wanghuiru_2020@qq.com+86 18116013393

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026